Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MAA868
MAA868
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
CP Wire
Wed, 02/27/19 - 10:52 am
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
Wed, 02/27/19 - 10:14 am
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
